共 50 条
- [41] SYNOVIAL-MEMBRANE HISTOLOGY AND IMMUNOPATHOLOGY IN RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS - INVIVO EFFECTS OF ANTIRHEUMATIC DRUGS ARTHRITIS AND RHEUMATISM, 1991, 34 (02): : 153 - 163
- [42] DO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS ACTUALLY MODIFY DISEASE COURSE IN RHEUMATOID-ARTHRITIS CLINICAL IMMUNOTHERAPEUTICS, 1994, 1 (05): : 319 - 322
- [43] COSTS AND BENEFITS OF CURRENT MONITORING POLICIES FOR SLOW-ACTING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S203 - S203
- [46] THE CYCLING OF COMBINATION ANTIRHEUMATIC DRUG-THERAPY IN RHEUMATOID-ARTHRITIS BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (06): : 445 - 450
- [47] CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO SLOW-ACTING ANTIRHEUMATIC DRUGS IN JUVENILE RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1988, 31 (01): : 15 - 20
- [48] RHEUMATOID-ARTHRITIS - OPPOSING ACTIONS OF HEMATOPOIETIC GROWTH-FACTORS AND SLOW-ACTING ANTIRHEUMATIC DRUGS LANCET, 1993, 342 (8870): : 536 - 539
- [49] ANTIMALARIAL-DRUGS FOR RHEUMATOID-ARTHRITIS AMERICAN JOURNAL OF MEDICINE, 1983, 75 (6A): : 48 - 58